Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
VRDN
Stock Latest News
The Fly
Viridian Therapeutics price target lowered to $26 from $27 at Evercore ISI
6d ago
VRDN
Premium
The Fly
Viridian Therapeutics price target lowered to $39 from $48 at Stifel
8d ago
VRDN
Premium
Company Announcements
Viridian Therapeutics Raises $359 Million in Offerings
10d ago
8K
VRDN
Premium
The Fly
Viridian Therapeutics 7.353M share Spot Secondary priced at $17.00
14d ago
VRDN
Premium
The Fly
Viridian Therapeutics price target raised to $34 from $30 at RBC Capital
14d ago
VRDN
Premium
Ratings
Viridian Therapeutics: REVEAL-2 Success and Strong Cash Runway Support Buy Rating, $32 Price Target Unchanged
16d ago
VRDN
Premium
Ratings
Analyst Reiterates Buy as Strong Phase III REVEAL-2 Data Boost Elegrobart’s Regulatory and Commercial Outlook
16d ago
VRDN
Premium
Company Announcements
Viridian Reports Positive Phase 3 Results in Thyroid Eye Disease
16d ago
8K
VRDN
Premium
The Fly
Viridian announces REVEAL-2 phase 3 study met primary endpoint
16d ago
VRDN
Premium
The Fly
Viridian Therapeutics reports Q1 EPS (90c), consensus ($1.09)
16d ago
VRDN
Premium
The Fly
Viridian Therapeutics price target lowered to $33 from $36 at Truist
30d ago
VRDN
Premium
Ratings
Viridian: Dual TED Franchise Catalysts Support Favorable Risk‑Reward and Buy Rating
1M ago
VRDN
Premium
The Fly
Viridian Therapeutics price target lowered to $24 from $32 at Evercore ISI
1M ago
VRDN
Premium
The Fly
Viridian Therapeutics price target lowered to $36 from $40 at Truist
1M ago
AMGN
VRDN
Premium
The Fly
Viridian Therapeutics price target lowered to $31 from $37 at Wedbush
1M ago
AMGN
VRDN
Premium
Market News
3 Best Trending Stocks, According to Analysts – 4/7/2026
1M ago
AMGN
NBIX
Premium
The Fly
Viridian Therapeutics price target lowered to $30 from $42 at RBC Capital
1M ago
VRDN
Premium
The Fly
Viridian Therapeutics removed from Best Ideas List at Wedbush
1M ago
VRDN
Premium
Ratings
Viridian: Pullback Seen as Overdone as Veligrotug Convenience and TED Portfolio Underscore Buy Rating
1M ago
VRDN
Premium
The Fly
Leerink sees weakness in Viridian Therapeutics shares as ‘overdone’
1M ago
AMGN
VRDN
Premium
Ratings
Buy Rating on Viridian: Elegrobart’s Convenience Edge and Overdone Share Price Pullback in Thyroid Eye Disease
1M ago
VRDN
Premium
The Fly
Midday Fly By: Neurocrine to acquire Soleno, Oracle hires new CFO
1M ago
WW
AMC
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
